Type 2 diabetes mellitus risk assessment using findrisc in patients with rheumatoid arthritis
Кондратьева Л. В., Попкова Т. В., Насонов Е. Л.
Научно-практическая ревматология
Т. 55, Вып. 5, С. 504-508
Опубликовано: 2017
Тип ресурса: Статья
DOI:10.14412/1995-4484-2017-504-508
Аннотация:
Objective: to investigate the prevalence of traditional risk factors (RFs) and to determine a 10-year risk for type 2 (T2) diabetes mellitus (DM), by using the Finnish Diabetes Risk Score (FINDRISC) in patients with rheumatoid arthritis (RA). Subjects and methods. The investigation enrolled 418 RA patients without a history of DM. The median age of the participants was 54 [41; 63] years; the median disease duration was 6 [2; 12] years. Most of the patients were positive for rheumatoid factor (75.6[%]) and anti-cyclic citrullinated peptide antibodies (77.3[%]) and had moderate and high RA activity (81.8[%]). Glucocorticoids (GCs), disease-modifying anti-rheumatic drugs, and biological agents were used in 42.1, 66.7, and 23.9[%] of the patients, respectively. FINDRISC was used to assess the risk of T2DM. A control group consisted of 100 gender- and age-matched individuals without inflammatory joint diseases or DM. Results and discussion. The most common modifiable traditional RFs in RA were abdo
Ключевые слова:
Diabetes mellitus; Hyperglycemia; Obesity; Questionnaire; Rheumatoid arthritis; Risk factors
Язык текста: Русский
ISSN: 1995-4492
Кондратьева Л. В.
Попкова Т. В.
Насонов Е. Л. Евгений Львович 1948-
Kondratyeva L. V.
Popkova T. V.
Nasonov E. L. Evgenij L`vovich 1948-
Type 2 diabetes mellitus risk assessment using findrisc in patients with rheumatoid arthritis
Текст визуальный непосредственный
Научно-практическая ревматология
ИМА-Пресс
Т. 55, Вып. 5 С. 504-508
2017
Статья
Diabetes mellitus Hyperglycemia Obesity Questionnaire Rheumatoid arthritis Risk factors
Objective: to investigate the prevalence of traditional risk factors (RFs) and to determine a 10-year risk for type 2 (T2) diabetes mellitus (DM), by using the Finnish Diabetes Risk Score (FINDRISC) in patients with rheumatoid arthritis (RA). Subjects and methods. The investigation enrolled 418 RA patients without a history of DM. The median age of the participants was 54 [41; 63] years; the median disease duration was 6 [2; 12] years. Most of the patients were positive for rheumatoid factor (75.6[%]) and anti-cyclic citrullinated peptide antibodies (77.3[%]) and had moderate and high RA activity (81.8[%]). Glucocorticoids (GCs), disease-modifying anti-rheumatic drugs, and biological agents were used in 42.1, 66.7, and 23.9[%] of the patients, respectively. FINDRISC was used to assess the risk of T2DM. A control group consisted of 100 gender- and age-matched individuals without inflammatory joint diseases or DM. Results and discussion. The most common modifiable traditional RFs in RA were abdo